2) Supporting Moderate, Sensible Prescription Drug Policies

    • Push for ideas like the federal Reduced Costs and Continued Cares Act (RCCCA), the sensible alternative to H.R. 3 that will lower costs and keep American innovation flowing
    • Avoid nationalized drug pricing systems (as in Canada, Britain and other countries) that not only dampen life-saving innovation but compromise patient access
    • Drive the Colorado state legislature to draft and pass sensible rebate reform legislation (link to CHAIN’s research paper)
    • Advance the use of biosimilar drugs to lower the overall cost and spend on prescription medicines (link to paper)